Innealta Capital LLC Invests $94,000 in DENTSPLY SIRONA Inc. (NASDAQ:XRAY)

Innealta Capital LLC acquired a new position in DENTSPLY SIRONA Inc. (NASDAQ:XRAYFree Report) during the 2nd quarter, according to the company in its most recent disclosure with the SEC. The fund acquired 3,755 shares of the medical instruments supplier’s stock, valued at approximately $94,000.

Several other hedge funds also recently made changes to their positions in XRAY. International Assets Investment Management LLC acquired a new position in shares of DENTSPLY SIRONA in the 4th quarter worth approximately $782,000. Louisiana State Employees Retirement System acquired a new position in shares of DENTSPLY SIRONA in the fourth quarter worth about $456,000. CWM LLC boosted its holdings in shares of DENTSPLY SIRONA by 18.2% in the fourth quarter. CWM LLC now owns 5,175 shares of the medical instruments supplier’s stock worth $184,000 after buying an additional 796 shares during the period. GAMMA Investing LLC acquired a new position in shares of DENTSPLY SIRONA in the fourth quarter worth about $55,000. Finally, Headlands Technologies LLC acquired a new position in shares of DENTSPLY SIRONA in the fourth quarter worth about $30,000. Institutional investors and hedge funds own 95.70% of the company’s stock.

DENTSPLY SIRONA Stock Performance

XRAY stock traded down $0.05 on Friday, reaching $25.29. 1,958,312 shares of the company were exchanged, compared to its average volume of 3,140,420. DENTSPLY SIRONA Inc. has a 12 month low of $23.58 and a 12 month high of $38.36. The stock’s fifty day moving average price is $25.31 and its 200 day moving average price is $28.75. The firm has a market capitalization of $5.25 billion, a PE ratio of -57.59, a PEG ratio of 1.22 and a beta of 1.01. The company has a debt-to-equity ratio of 0.57, a current ratio of 1.33 and a quick ratio of 0.87.

DENTSPLY SIRONA (NASDAQ:XRAYGet Free Report) last announced its earnings results on Wednesday, July 31st. The medical instruments supplier reported $0.49 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.50 by ($0.01). DENTSPLY SIRONA had a positive return on equity of 11.86% and a negative net margin of 4.75%. The company had revenue of $984.00 million for the quarter, compared to the consensus estimate of $993.61 million. During the same period last year, the firm posted $0.51 EPS. The company’s revenue was down 4.3% compared to the same quarter last year. On average, research analysts anticipate that DENTSPLY SIRONA Inc. will post 1.99 EPS for the current fiscal year.

DENTSPLY SIRONA Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, October 11th. Investors of record on Friday, September 27th will be given a dividend of $0.16 per share. This represents a $0.64 dividend on an annualized basis and a yield of 2.53%. The ex-dividend date of this dividend is Friday, September 27th. DENTSPLY SIRONA’s dividend payout ratio (DPR) is currently -145.45%.

Wall Street Analyst Weigh In

Several brokerages have commented on XRAY. Piper Sandler reiterated a “neutral” rating and issued a $32.00 target price (down from $35.00) on shares of DENTSPLY SIRONA in a report on Friday, May 3rd. Robert W. Baird cut their price objective on shares of DENTSPLY SIRONA from $33.00 to $31.00 and set a “neutral” rating on the stock in a research report on Monday, July 22nd. Evercore ISI cut their price objective on shares of DENTSPLY SIRONA from $28.00 to $27.00 and set an “outperform” rating on the stock in a research report on Tuesday, July 9th. Needham & Company LLC reaffirmed a “buy” rating and set a $34.00 price objective on shares of DENTSPLY SIRONA in a research report on Tuesday, August 20th. Finally, Barrington Research reaffirmed an “outperform” rating and set a $38.00 price objective on shares of DENTSPLY SIRONA in a research report on Monday, July 8th. Five research analysts have rated the stock with a hold rating and seven have assigned a buy rating to the stock. Based on data from MarketBeat, DENTSPLY SIRONA presently has an average rating of “Moderate Buy” and an average target price of $33.44.

Check Out Our Latest Report on DENTSPLY SIRONA

About DENTSPLY SIRONA

(Free Report)

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.

Read More

Want to see what other hedge funds are holding XRAY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for DENTSPLY SIRONA Inc. (NASDAQ:XRAYFree Report).

Institutional Ownership by Quarter for DENTSPLY SIRONA (NASDAQ:XRAY)

Receive News & Ratings for DENTSPLY SIRONA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA and related companies with MarketBeat.com's FREE daily email newsletter.